CVA
16
1
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
6.3%
1 terminated out of 16 trials
90.0%
+3.5% vs benchmark
0%
0 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF
Robotic Exoskeleton Assisted Gait Post Stroke
COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO)
DDN in Stroke--COBRE
Acute Effects of Beetroot Juice on Locomotor Economy and Capacity in Chronic Stroke
Monitoring Neurological Deterioration in Anaesthetised Patients With Electroencephalogram (EEG)
CVA in Patients Suffering From Decreased Consciousness, Confusion or Headaches to an Emergency Room
Treatment Intensity - Apraxia of Speech
Transcutaneous Spinal and Peripheral Stimulation and Wrist Robotic Therapy for Patients With Spastic Stroke
Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.
Healthy Lifestyles After Stroke - Stroke Coach
Effects of Two Different Types of Ankle Foot Orthoses on Gait Outcomes in Patients With Subacute Stroke.
Feasability, Validty and Reliability of Inertial Sensors
Independence Stairs Climbing Ability Prediction During the Sub-acute Rehabilitation Phase of People After Stroke
Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)